Matthew L Hedberg

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 7

Top Venues

Journal of cutaneous pathology

PLoS pathogens

Scientific reports

The Journal of experimental medicine

University of Pittsburgh School of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Pittsburgh School of Medicine Jun 01 2010 - Dec 22 2016

United States

PHD :: MSTP, Pharmacology and Molecular Biology

Publications

Kang I Ko, Jean J Merlet, Brett P DerGarabedian, Huang Zhen, Yoko Suzuki-Horiuchi, Matthew L Hedberg, Eileen Hu, Anh T Nguyen, Stephen M Prouty, Faizan Alawi, Matthew C Walsh, Yongwon Choi, Sarah E Millar, Ashley Cliff, Jonathon Romero, Michael R Garvin, John T Seykora, Daniel A Jacobson, Dana T Graves
NF-κB perturbation reveals unique immunomodulatory functions in Prx1 + fibroblasts that promote development of atopic dermatitis. Science translational medicine 14 (630) (2022)
Matthew L Hedberg, Corbett T Berry, Ata S Moshiri, Yan Xiang, Christopher J Yeh, Cem Attilasoy, Brian C Capell, John T Seykora
Molecular Mechanisms of Cutaneous Squamous Cell Carcinoma. International journal of molecular sciences 23 (7) (2022)
Jacob Beer, Julie Bittar, Matthew L Hedberg, John T Seykora
Violaceous truncal plaques consistent with amyloid light-chain amyloidosis. Journal of cutaneous pathology (2021)
Matthew L Hedberg, Rebecca J Chibnall, Leigh A Compton
Symptomatic vulvar demodicosis: A case report and review of the literature. Journal of cutaneous pathology 47 (11) (2020)
Matthew L Hedberg, Noah D Peyser, Julie E Bauman, William E Gooding, Hua Li, Neil E Bhola, Tian Ran Zhu, Yan Zeng, Toni M Brand, Mi-Ok Kim, Richard C K Jordan, Scott VandenBerg, Victor Olivas, Trever G Bivona, Simion I Chiosea, Lin Wang, Gordon B Mills, Jonas T Johnson, Umamaheswar Duvvuri, Robert L Ferris, Patrick Ha, Daniel E Johnson, Jennifer R Grandis
Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for PIK3CA-altered head and neck cancer. The Journal of experimental medicine 216 (2) (2019)
Alissa R Young, Marissa C Locke, Lindsey E Cook, Bradley E Hiller, Rong Zhang, Matthew L Hedberg, Kristen J Monte, Deborah J Veis, Michael S. Diamond, Deborah J Lenschow
Dermal and muscle fibroblasts and skeletal myofibers survive chikungunya virus infection and harbor persistent RNA. PLoS pathogens 15 (8) (2019)
Kara S Meister, Neal R Godse, Nayel I Khan, Matthew L Hedberg, Carolyn Kemp, Sucheta Kulkarni, Diego Alvarado, Theresa LaVallee, Seungwon Kim, Jennifer R Grandis, Umamaheswar Duvvuri
HER3 targeting potentiates growth suppressive effects of the PI3K inhibitor BYL719 in pre-clinical models of head and neck squamous cell carcinoma. Scientific reports 9 (1) (2019)

Matthew L Hedberg.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Matthew L Hedberg